Inventiva S.A. (IVA)
NASDAQ·Healthcare·Biotechnology
$5.02
-2.14%
Mkt Cap $331.65M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $5.15M | $2.30M | -55.34% | -$0.28 | -$1.07 | -282.14% | — | — |
| Q3 2025 Sep 25, 2025 | $8.67M | $5.22M | -39.84% | -$0.41 | -$1.89 | -361.73% | — | — |
| Q2 2025 May 23, 2025 | $6.40M | $6.69M | +4.61% | -$0.47 | -$2.69 | -472.95% | — | — |
| Q3 2024 Sep 25, 2024 | — | $2.94M | — | -$0.56 | -$1.01 | -81.10% | — | — |
| Q1 2024 Mar 27, 2024 | $15.30M | $18.19M | +18.93% | -$0.40 | -$1.25 | -211.66% | — | — |
| Q3 2023 Sep 28, 2023 | $1.39M | $7.22M | +419.32% | -$1.27 | -$1.43 | -13.09% | — | — |
| Q1 2023 Mar 29, 2023 | $15.70M | $16.61M | +5.80% | -$0.57 | -$0.64 | -11.90% | — | — |
| Q3 2022 Sep 19, 2022 | $1.26M | $70.08K | -94.44% | -$0.90 | -$0.75 | +16.59% | — | — |
| Q1 2022 Mar 3, 2022 | $3.50M | $4.60M | +31.17% | -$0.90 | -$0.76 | +15.33% | — | — |
| Q3 2021 Sep 20, 2021 | $118.84K | $77.12K | -35.11% | -$0.91 | -$0.46 | +48.96% | — | — |
| Q4 2020 Dec 31, 2020 | $4.97M | $258.76K | -94.80% | -$0.82 | -$0.57 | +29.96% | — | — |
| Q3 2020 Sep 16, 2020 | $4.13M | $83.27K | -97.98% | -$0.69 | -$0.32 | +53.20% | — | — |
| Q4 2019 Dec 31, 2019 | — | $6.43M | — | — | -$0.41 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | $4.01M | — | — | -$1.05 | — | — | — |
| Q4 2018 Dec 31, 2018 | — | $3.85M | — | — | -$0.91 | — | — | — |
| Q2 2018 Jun 30, 2018 | — | $4.83M | — | — | -$1.00 | — | — | — |
| Q4 2017 Dec 31, 2017 | — | $5.52M | — | — | -$0.67 | — | — | — |
| Q2 2017 Jun 30, 2017 | — | $5.98M | — | — | -$0.76 | — | — | — |
| Q4 2016 Dec 31, 2016 | — | $7.97M | — | — | -$0.31 | — | — | — |
| Q2 2016 Jun 30, 2016 | — | $7.49M | — | — | -$0.45 | — | — | — |